Israeli Scientists Find New Hope for Prostate Cancer
Researchers at the Weizmann Institute discovered why half of prostate cancers resist treatment and identified a potential solution already approved by the FDA. The breakthrough could transform care for 700,000 men diagnosed with this cancer type annually.